Renaissance Technologies - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 40 filers reported holding OVID THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$310
-17.6%
80,800
-29.6%
0.00%0.0%
Q2 2023$376
+20.9%
114,700
-4.9%
0.00%
Q1 2023$311
+39.5%
120,600
+0.7%
0.00%
Q4 2022$223
-99.9%
119,800
+0.8%
0.00%
Q3 2022$219,000
-17.7%
118,800
-4.0%
0.00%
Q2 2022$266,0000.0%123,800
+46.0%
0.00%
Q1 2022$266,000
+41.5%
84,800
+44.7%
0.00%
Q4 2021$188,000
+62.1%
58,600
+69.9%
0.00%
Q3 2021$116,000
-92.9%
34,500
-95.1%
0.00%
-100.0%
Q4 2020$1,641,000
-64.3%
710,507
+13.8%
0.00%
-50.0%
Q2 2020$4,600,000
+81.0%
624,109
-26.8%
0.00%
+100.0%
Q1 2020$2,541,000
-43.6%
852,843
-21.4%
0.00%
-33.3%
Q4 2019$4,502,000
+136.8%
1,084,709
+84.9%
0.00%
+50.0%
Q3 2019$1,901,000
+118.0%
586,725
+24.4%
0.00%
+100.0%
Q2 2019$872,000
+35.6%
471,609
+29.8%
0.00%0.0%
Q1 2019$643,000
+383.5%
363,217
+559.2%
0.00%
Q4 2018$133,00055,1000.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
TLS Advisors LLC 1,380,346$3,51618.08%
Madison Avenue Partners, LP 3,104,603$8,009,8761.72%
BVF INC/IL 6,851,051$17,675,7120.65%
CHI Advisors LLC 864,822$2,231,2410.59%
EcoR1 Capital, LLC 6,117,400$15,782,8920.51%
Rubric Capital Management LP 7,001,124$18,062,9000.47%
Artal Group S.A. 2,500,000$6,4500.38%
Tejara Capital Ltd 118,791$306,4810.16%
DCF Advisers, LLC 68,264$176,1200.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 827,580$2,135,1560.06%
View complete list of OVID THERAPEUTICS INC shareholders